Cannabidiol: An Overview of Some Pharmacological Aspects.
Mechoulam, Raphael; Parker, Linda A.; Gallily, Ruth
Journal of Clinical Pharmacology.
42(11) SUPPLEMENT:11S-19S, November 2002.
(Format: HTML, PDF)
Over the past few years, considerable attention has focused on cannabidiol (CBD), a major nonpsychotropic constituent of cannabis. The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD. CBD does not bind to the known cannabinoid receptors, and its mechanism of action is yet unknown. It is possible that, in part at least, its effects are due to its recently discovered inhibition of anandamide uptake and hydrolysis and to its antioxidative effect.
(C)2002 SAGE Publications